Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) trial: Rationale and study design

Am Heart J. 2020 Apr:222:174-182. doi: 10.1016/j.ahj.2020.01.018. Epub 2020 Jan 28.
No abstract available

Publication types

  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Coated Materials, Biocompatible*
  • Coronary Angiography
  • Coronary Restenosis / complications
  • Coronary Restenosis / diagnosis
  • Coronary Restenosis / surgery*
  • Diabetes Mellitus*
  • Drug-Eluting Stents*
  • Female
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents / pharmacology
  • Male
  • Percutaneous Coronary Intervention / methods*
  • Polymers
  • Prospective Studies
  • Prosthesis Design
  • Single-Blind Method
  • Sirolimus / analogs & derivatives*
  • Sirolimus / pharmacology*
  • Treatment Outcome

Substances

  • Coated Materials, Biocompatible
  • Immunosuppressive Agents
  • Polymers
  • zotarolimus
  • Sirolimus